InsiderLens

fi_swedentransaction_report25 Mar 2025fi_sweden:be501f94e8876fa7e4870a1ba104d53c

fi_swedentransaction_report24 Mar 2025fi_sweden:aa0ff6dc4517d5a707c954d7f306eee6

fi_swedentransaction_report24 Oct 2024fi_sweden:1306acd4f45d5684be0efcb848cdf8ce

fi_swedentransaction_report24 Oct 2024fi_sweden:f0ba118246fe3e2c13a00c1b91fc2bcd

fi_swedentransaction_report24 Oct 2024fi_sweden:7be32cb60f72e4c13006bc16667d2897

fi_swedentransaction_report23 Oct 2024fi_sweden:fc662e77ea5fc27acdd198920fd3b339

fi_swedentransaction_report23 Oct 2024fi_sweden:93adea666a89bd3a0988348d63bd2a2c

fi_swedentransaction_report03 Jul 2024fi_sweden:53e9ab79b624e102f6798eba84be83dc

fi_swedentransaction_report03 Jul 2024fi_sweden:929594c0382736b846ea9e2bb84e442d

fi_swedentransaction_report13 Jun 2024fi_sweden:436bc8875dd0faef2a66c909bc9c9540

fi_swedentransaction_report08 Jun 2024fi_sweden:4e70b8eae34532c309cd7e1fa6a48072amend

fi_swedentransaction_report05 Jun 2024fi_sweden:b3087867246a46ccc7009e81dbf92950

fi_swedentransaction_report04 Jun 2024fi_sweden:26472a05e4472e2cdb38d9e05060fe9d

fi_swedentransaction_report30 May 2024fi_sweden:df98a01234fc6541d42ecb2d74511802

fi_swedentransaction_report29 May 2024fi_sweden:422295821c57728f6397b0dbfff47200amend

fi_swedentransaction_report29 May 2024fi_sweden:50c3015fef25f2cc4524da4e18938fb5

fi_swedentransaction_report29 May 2024fi_sweden:0800ad3305b434fca3f346266052ff5d

fi_swedentransaction_report29 May 2024fi_sweden:f9453b84cf2aa8afb28062e36a2db557

fi_swedentransaction_report20 Dec 2023fi_sweden:62901820e674683644582ff9fb701f2d

fi_swedentransaction_report19 Dec 2023fi_sweden:cd58a4b2d3bdb24b96fb22293fc12da0

fi_swedentransaction_report19 Dec 2023fi_sweden:ba2ce21d0200df1b5aa3e67b1ac9f99b

fi_swedentransaction_report18 Dec 2023fi_sweden:6402401317c819b4ccc0032dda22cff8

fi_swedentransaction_report17 Jun 2022fi_sweden:6f5b56f441646a0b4f9c797612a2f899

fi_swedentransaction_report17 Mar 2022fi_sweden:4792344b52d69acc2d017f014c25c1e3amend

fi_swedentransaction_report16 Mar 2022fi_sweden:48a50cd09cd4ab9633bf89e3aece7124

Annexin Pharmaceuticals via Annexin Incentive.